Boston An independent LDT provider

Press releases

March 10, 2022 | REGULATORY

Immunovia publishes the annual report for 2021

Read press release
March 8, 2022

Immunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists – a major step in the nationwide US roll-out of IMMray™ PanCan-d

Read press release
March 7, 2022

Immunovia further strengthens IP portfolio for its IMMray™ PanCan-d signature

Read press release
March 4, 2022 | REGULATORY

Notice to the Annual General Meeting of Immunovia AB (publ)

Read press release
February 22, 2022

Immunovia invited to the 42nd Annual Cowen Health Care Conference

Read press release
February 17, 2022 | REGULATORY

Immunovia Publishes Full Year Report 2021

Read press release
February 17, 2022

IMMray™ PanCan-d – peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology

Read press release
February 4, 2022

Invitation to Immunovia’s Q4 presentation

Read press release
February 3, 2022 | REGULATORY

Immunovia postpones Annual General Meeting pending the Temporary Meetings Act

Read press release
January 20, 2022 | REGULATORY

Immunovia appoints Philipp Mathieu as Acting CEO

Read press release
November 30, 2021 | REGULATORY

Immunovia’s CEO to step down during 2022

Read press release
November 26, 2021

Immunovia appoints new Senior Director Investor Relations and Corporate Communications

Read press release
1 2 3 4 22